Paclitaxel and albumin nanoparticles combined with bevacizumab for cancer

• 收藏
• 分享

专利权人:

バイオサイエンス，;アブラクシス;エルエルシー;アブラクシス バイオサイエンス, エルエルシー

发明人:

デサイ， ニール ピー．,スーン－シオン， パトリック,デサイ, ニール ピー.,スーン-シオン, パトリック

申请号：

JP2009536282

公开号：

JP5931323B2

申请日:

2007.11.06

申请国别(地区):

JP

年份:

2016

代理人:

摘要：

The present invention provides combination therapy methods of treating proliferative diseases (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy which may include, for example, radiation, surgery, administration of chemotherapeutic agents (such as an anti-VEGF antibody), or combinations thereof. Also provided are methods of administering to an individual a drug taxane in a nanoparticle composition based on a metronomic dosing regime.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/